Mochida Pharmaceutical Group traces its origins opening a pharmacy in Hongo, Tokyo in 1913 and began manufacturing pharmaceuticals based on a belief in “innovative research.”
Since its foundation, we have consistently grown by contributing to medical advances in Japan as the first company in Japan to manufacture injections and a developer of "unique products" encompassing hormones, enzymes and immunology, in line with our motto "farsighted, innovative research."
Our corporate philosophy "Actively contributing to human health and well-being in the field of medicine, totally committed to the development of innovative products " is our universal mission. We believe that our raison d'être is to create and provide valuable products to patients and customers by capturing potential medical and healthcare needs to help people suffering from illness or health problems.
As the aging of society progresses and the environment for medical services continues to change dramatically, concerns about health and expectations for medical care are increasing. We see increasingly diverse medical and healthcare needs as a business opportunity and are also ready to adapt to changes in the business environment. In our core pharmaceutical business, we will continue creating useful new drugs and will also tackle new business areas such as biomaterials and regenerative medicine. In the healthcare business, we will continue focusing on the development of skin care products based on dermatology.
We set out our fundamental approach for conducting corporate activities, striving for compliance, and contributing to the realization of a sustainable society in Mochida Pharmaceutical Group Code of Conduct. Every employee of the Group always acts with high ethical standards. We take pride as a pharmaceutical company and take medical care seriously, and place great importance on the stable supply of high quality pharmaceuticals, the proper handling of information, and the securing of proper profits. We hope to be a company that is trusted by our stakeholders.
We will contribute even more to people's health and well-being by squarely facing medical and healthcare needs and providing innovative value-added products to address them.
Naoyuki Mochida
Representative Director, President